Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human nerve growth factor

EU orphan designation number: EU/3/15/1586   
Active ingredient: Recombinant human nerve growth factor
Indication: Treatment of neurotrophic keratitis
Sponsor: Dompé farmaceutici S.p.A.
Via Santa Lucia 6, 20122 Milano, Italia
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name OXERVATE on 06/07/2017 with the number EU/1/17/1197

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/12/2015 Orphan designation EMA/OD/143/15 (2015)9508 of 14/12/2015
29/01/2016 Change of name and/or address of sponsor